Preclinical Development of ADCT-601, a Novel Pyrrolobenzodiazepine Dimer-based Antibody–drug Conjugate Targeting AXL-expressing Cancers

por Zammarchi, Francesca, Havenith, Karin EG., Chivers, Simon, Hogg, Paul, Bertelli, Francois, Tyrer, Peter, Janghra, Narinder, Reinert, Halla W., Hartley, John A., van Berkel, Patrick H.
Publicado 2022

Upregulation of mucin glycoprotein MUC1 in the progression to esophageal adenocarcinoma and therapeutic potential with a targeted photoactive antibody-drug conjugate

por Butt, Mohammed Adil, Pye, Hayley, Haidry, Rehan J., Oukrif, Dahmane, Khan, Saif-U-Rehman, Puccio, Ignazio, Gandy, Michael, Reinert, Halla W., Bloom, Ellie, Rashid, Mohammed, Yahioglu, Gokhan, Deonarain, Mahendra P., Hamoudi, Rifat, Rodriguez-Justo, Manuel, Novelli, Marco R., Lovat, Laurence B.
Publicado 2017

Using antibody directed phototherapy to target oesophageal adenocarcinoma with heterogeneous HER2 expression

por Pye, Hayley, Butt, Mohammed Adil, Funnell, Laura, Reinert, Halla W., Puccio, Ignazio, Rehman Khan, Saif U., Saouros, Savvas, Marklew, Jared S., Stamati, Ioanna, Qurashi, Maryam, Haidry, Rehan, Sehgal, Vinay, Oukrif, Dahmane, Gandy, Michael, Whitaker, Hayley C., Rodriguez-Justo, Manuel, Novelli, Marco, Hamoudi, Rifat, Yahioglu, Gokhan, Deonarain, Mahendra P., Lovat, Laurence B.
Publicado 2018